Aquestive Therapeutics, Inc. logo AQST - Aquestive Therapeutics, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 10
HOLD 0
SELL 0
STRONG
SELL
0
| PRICE TARGET: $9.75 DETAILS
HIGH: $12.00
LOW: $6.00
MEDIAN: $10.00
CONSENSUS: $9.75
UPSIDE: 109.23%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Stable Earnings Power

AlphaQuality — archetype-weighted quantitative grade

F 9.7 / 100 pillar composite

Composite Grade

Composite of six pillars weighted for stable earnings power businesses. Purely quantitative — the six pillars score only reported financials, no analyst input.

⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.

Grade overrides the 9.7 pillar composite because hard gates always win. Use the pillar breakdown below to see where the underlying numbers sit.

Profitability

Weight: 20%
F 0.0
  • Operating Margin Trend -14.15 pp/yr 0/100
Contributes 0.0 pts toward composite.

Capital Efficiency

Weight: 15%
F 0.0
  • 5yr Share-Count CAGR 29.4% 0/100
Contributes 0.0 pts toward composite.

Growth Quality

Weight: 15%
D- 31.5
  • 5yr Revenue CAGR -0.6% 19/100
  • Revenue-Growth Years (5) 3/5 60/100
Contributes 4.7 pts toward composite.

Cash Generation

Weight: 15%
F 0.0
  • 5yr FCF Margin -57.7% 0/100
  • 5yr FCF/NI Conversion 0.00x 0/100
Contributes 0.0 pts toward composite.

Balance Sheet

Weight: 20%
F 0.0
  • Net Debt / EBITDA 10.00x 0/100
  • Interest Coverage (EBIT/Int) -3.90x 0/100
  • Altman Z-Score -2.43 0/100
Contributes 0.0 pts toward composite.

Stability

Weight: 15%
D 33.3
  • Negative-Revenue Years (5) 2/5 60/100
  • Piotroski F-Score 1 11/100
Contributes 5.0 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

1 of 2 gurus held; 1 added; 1 full exit.

Holders
1 -1
Avg Δ position
+107.4%
New buys
0
Full exits
1
As of Q2 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (20%) — Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Share-Count CAGR
  • Growth Quality (15%) — 5yr Revenue CAGR, Revenue-Growth Years (5)
  • Cash Generation (15%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (20%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (15%) — Negative-Revenue Years (5), Piotroski F-Score

The six pillars read only reported financial-statement fields — no analyst targets or consensus ratings. The archetype that picks which pillar formulas apply is not fully price-free, though: it can route a company to the distressed/ungradable archetype based on price vs. its 52-week high, and beta affects one classification check. A minimum of 5 fiscal years of audited statements is required. Insurers and banks are graded on their own methodology — insurers on loss ratio, its trend and stability, and premiums-to-surplus; banks on the efficiency ratio, its trend and stability, and equity-to-assets — rather than on industrial margin/ROIC signals. Distressed, highly leveraged infrastructure, asset-manager, and other financial businesses are declared ungradable rather than forced into a numeric score.